Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1419]

Practical implementation of proton therapy in the UK

Prof Karol Sikora - Proton Partners International, Cardiff, UK

Practical implementation of proton therapy in the UK ( Prof Karol Sikora - Proton Partners International, Cardiff, UK )

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General

IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA

Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )

Diet, transplacental carcinogenesis and risk to children: results from the...

Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens...

Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project ( Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens, Greece )

VISMO trial to treat basal cell carcinoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany

VISMO trial to treat basal cell carcinoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

Checkpoint inhibitor therapy for treating melanoma

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA

Checkpoint inhibitor therapy for treating melanoma ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )

Metabolomics: Reversing drug resistance

Dr Olivier Pardo - Imperial College London, London, UK

Metabolomics: Reversing drug resistance ( Dr Olivier Pardo - Imperial College London, London, UK )

PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK

PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK )

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

Editor's Choice for August 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )

Breaking down barriers to cancer communication worldwide

Prof Gordon McVie - Editor in Chief, ecancer

Breaking down barriers to cancer communication worldwide ( Prof Gordon McVie - Editor in Chief, ecancer )

Drug repurposing in review

Dr Farhat Khanim – University of Birmingham, Birmingham, UK

Drug repurposing in review ( Dr Farhat Khanim – University of Birmingham, Birmingham, UK )

Tumour metabolism in chemoprevention

Dr Farhat Din – The University of Edinburgh, Edinburgh, UK

Tumour metabolism in chemoprevention ( Dr Farhat Din – The University of Edinburgh, Edinburgh, UK )

More from ecancer